Matches in Nanopublications for { ?s ?p "[CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1290145.RAbGHyOMaB8I4nB_eyJEP_B9YLASwBDLR8iyp89EGjQFA130_assertion description "[CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1290145.RAbGHyOMaB8I4nB_eyJEP_B9YLASwBDLR8iyp89EGjQFA130_provenance.
- NP1290146.RA71iJY8Eqks2ItqOVZK9IZlXet9DjRnMvpojx_OCAb1s130_assertion description "[CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1290146.RA71iJY8Eqks2ItqOVZK9IZlXet9DjRnMvpojx_OCAb1s130_provenance.